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Abstract
Background: Here we present a novel promising microbial diagnostic method that combines the
sensitivity of Nucleic Acid Sequence Based Amplification (NASBA) with the high information
content of microarray technology for the detection of bacterial tmRNA molecules. The NASBA
protocol was modified to include aminoallyl-UTP (aaUTP) molecules that were incorporated into
nascent RNA during the NASBA reaction. Post-amplification labeling with fluorescent dye was
carried out subsequently and tmRNA hybridization signal intensities were measured using
microarray technology. Significant optimization of the labeled NASBA protocol was required to
maintain the required sensitivity of the reactions.
Results:  Two different aaUTP salts were evaluated and optimum final concentrations were
identified for both. The final 2 mM concentration of aaUTP Li-salt in NASBA reaction resulted in
highest microarray signals overall, being twice as high as the strongest signals with 1 mM aaUTP
Na-salt.
Conclusion: We have successfully demonstrated efficient combination of NASBA amplification
technology with microarray based hybridization detection. The method is applicative for many
different areas of microbial diagnostics including environmental monitoring, bio threat detection,
industrial process monitoring and clinical microbiology.
Background
There is a growing need for quick and highly parallel
approaches to microorganism detection and identifica-
tion worldwide. In this paper we present a molecular diag-
nostics method that combines isothermal amplification
of target tmRNA molecule with microarray-based detec-
tion. Nucleic Acid Sequence Based Amplification
(NASBA) is a sensitive isothermal RNA amplification
technology [1] that offers several advantages over the
more commonly used PCR-based methods: it requires
simplified equipment, is less sensitive to genomic DNA
contamination and therefore more suitable for applica-
tions where microbial viability is important [2]. In micro-
bial diagnostics, NASBA has been successfully combined
with electrochemiluminescent (ECL) [3] ELISA [4] labeled
dendrimer [5] and molecular beacon-based [6] methods
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to detect and identify viral and bacterial pathogens. DNA
microarrays have recently shown great potential in micro-
bial diagnostics; in investigation of microbial diversity,
composition and species identification from environmen-
tal and medical samples [7,8]. In microarray experiments
amplified nucleic acid sequences of interest are usually
labeled prior to the hybridization experiment. Use of flu-
orescent labeling protocols for different amplification
methods have previously been described [9-12], but to
our knowledge no method has been published for direct
labeling of NASBA amplified products. Previously pub-
lished NASBA product labeling methods like NASBA-
ELISA [4] and NAIMA [5] all require additional secondary
enzymatic steps to complete the protocol. Introduction of
microarray based detection to NASBA offer the new
potential for rapid simultaneous identification of many
different amplification products and/or pathogens. Deli-
cate and precise reaction conditions have to be present for
NASBA amplification of target RNA with high efficiency,
as the method requires simultaneous cooperation and
balance between three different enzymes (reverse tran-
scriptase, RNaseH and T7 RNA polymerase) and their
respective buffers. Any further modifications to the gold
standard NASBA protocol (like the one developed by
bioMerieux, patent holder for NASBA technology) for
microarray purposes, require cautious approach and care-
fully conducted experiments in order to maintain ade-
quate RNA amplification yield. The objective of our work
is to present a method that combines simple one-step flu-
orescent labeling of NASBA amplified tmRNA product
with microarray hybridization and detection. TmRNA
products of bacterial ssrA  genes were used as markers
because they contain regions of sequence heterogenecity
that have previously been successfully applied for micro-
bial diagnostics [13,14]. Aminoallyl modified UTPs (aaU-
TPs) were incorporated into nascent RNAs in the NASBA
reaction. Following the amplification process, aaUTP
modified RNAs were labeled with aminoreactive fluores-
cent marker Cy3. Fluorescently labeled tmRNA was then
used in microarray hybridization experiments. Optimal
concentrations for two different aaUTP-salts in NASBA
reaction were determined.
Results and Discussion
Addition of aaUTP to NASBA mix resulted in a concentra-
tion-dependent effect on the reaction performance. Con-
centrations of up to 0,5 mM for sodium salt and 1 mM for
lithium salt did not influence NASBA efficiency as seen
from the amount of RNA produced (Fig. 1A), whereas
higher concentrations did inhibit the amplification effi-
ciency. The exact ratio of aaUTP to rUTP (and to all the
other nucleotides correspondingly) and its influence on
NASBA reactions cannot be determined precisely as the
manufacturer's protocol do not provide information
about the composition of Reagent sphere (component of
bioMerieux NASBA kit containing NTP and dNTP mole-
cules). Fig. 1A shows the average amount of RNA product
generated with amplification reactions comparing aaUTP
sodium salt to the aaUTP lithium salt. Specific amplifica-
tion of S. pneumoniae tmRNA molecules was verified by
observing only one peak of predicted size (307 nucle-
otides) nucleic acid on RNA 6000 chip electropherogram.
Respective microarray signal intensities of labeled NASBA
products are shown on Fig. 1B. Data for aautp lithium salt
concentrations from 0,125 mM to 8 mM and for aaUTP
sodium salt concentrations from 0,125 mM to 2 mM are
given, respectively. Increased microarray signal intensity
was observed in parallel with increasing aminoallyl-UTP
concentration in NASBA reaction up to 1 mM for sodium
and 2 mM for lithium salt. For aaUTP lithium salt the final
concentrations within the range of 1 mM and 2 mM
resulted in the highest average microarray signals, while
highest average signals with aaUTP sodium salt were
obtained between 0,5 mM and 1 mM aaUTP concentra-
tion, respectively. The final 2 mM concentration of aaUTP
Li-salt in NASBA reaction resulted in highest microarray
signals overall, being twice as high as the strongest signals
with 1 mM aaUTP Na-salt.
The aim of this work was to improve and expand the
potential of a combined NASBA-microarray approach by
developing a new optimized protocol suitable for further
possible use in microbial diagnostics. All together, we
have introduced a new method suitable for high-speed
parallel detection of RNA targets. NASBA technology,
widely used in various microbiology laboratories all over
the world, is for the first time combined with microarray
based RNA detection technology using simple one-step
NASBA product labeling method. Previous methods
described so far for NASBA amplicon detection have used
additional enzymatic steps after the amplification and sec-
ondary labeled probes [4,5]. In our case, the NASBA pro-
tocol was modified by addition of aminoallyl-UTP
molecules allowing labeling of the reaction product with
aminoreactive fluorescent marker. Indirect labeling of
RNA for microarray purposes via incorporation of aaUTPs
was preferred over direct incorporation of fluorescently
labeled nucleotides, as it has been proved to be more effi-
cient with T7 RNA polymerase based methods [12]. Two
different aaUTP salts were compared and both enabled
sufficient fluorophore incorporation providing easily
detectable microarray signals. Considering that ami-
noallyl-UTPs tested in the current report are produced as
different salts, this may contribute to the difference in
RNA quantity in NASBA reaction (Fig. 1A) causing
decrease in microarray signal intensities (Fig. 1B). The
aaUTP Na-salt may have more negative impact than the
Li-salt aaUTP on the co-operation of the NASBA enzymes.
Different monovalent cations have previously been
shown to have unequal impact on similar enzymatic reac-BMC Biotechnology 2009, 9:45 http://www.biomedcentral.com/1472-6750/9/45
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Results of Streptococcus pneumoniae tmRNA specific NASBA amplifications Figure 1
Results of Streptococcus pneumoniae tmRNA specific NASBA amplifications. A) Average RNA quantity after NASBA 
amplification with different aaUTP salts. Error bars show ± one SD of these averages. Control value stands for RNA amount in 
NASBA reaction without aaUTP addition. B) Comparison of average relative microarray signal intensities from NASBA exper-
iments conducted with a range of concentrations of two different aaUTP. Error bars show ± one SD of these averages. Signal 
intensity value 1 stands for average signal intensity of every dilution series experiment including data from both used aaUTP 
salts.
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tions [15]. However, as the manufactures do not provide
exact composition of aaUTP storage solution, other
unknown components may also contribute to the
observed difference in behaviour of used aminoallyl-
UTPs.
Conclusion
In general we have presented here a new optimized proto-
col for highly potential microarray based detection of
NASBA amplified RNA products. Our method is suitable
for further possible diagnostic applications where rapid
identification of various RNA molecules from bacteria or
different microorganisms is needed. The combination of
NASBA with microarray detection is particularly advanta-
geous in settings where different bacterial species may be
present (such as environmental samples) or in clinical set-
tings where it is necessary to identify one particular infec-
tion causing species from a panel of potential pathogens.
Methods
Bacterial strain and total RNA purification
Streptococcus pneumoniae strain ATCC 33400 (DSMZ,
Braunschweig, Germany) was grown in Brain Heart Infu-
sion Broth (Oxoid, Hampshire, UK). Total RNA was puri-
fied from overnight cultures using RiboPure Yeast Kit
(Ambion, Austin, TX, USA). Although the RiboPure Yeast
kit is not originally intended for RNA extraction from bac-
teria, high quality bacterial total RNA was obtained with-
out making any modifications to manufacturer's
instructions.
NASBA
NASBA primer pair (Table 1) was designed to amplify
near full-length 307 nucleotide tmRNA product from S.
pneumoniae total RNA. Conventional NASBA, in which the
T7 promoter is included in the reverse primer, generates
an antisense RNA product [1]. In order to generate sense
strand of tmRNA the T7 promoter sequence was posi-
tioned on the forward primer instead of the reverse, as
described previously [16]. NASBA reactions were per-
formed with 10 ng of template total RNA using Nucli-
SENS EasyQ Basic Kit v2 (bioMerieux bv, Boxtel, NL)
according to the manufacturer's instructions. Aminoallyl-
UTP was added to the reaction mix (final volume 20 μl) at
concentrations ranging from 0,125 mM to 8 mM. Equal
volume of NASBA water (bioMerieux) was added to con-
trol experiment without any aaUTP, to set a baseline for
determination of amplification efficiency. Two different
aminoallyl-UTP solutions: aaUTP Li-salt (Epicentre, Mad-
ison, WI, USA) and aaUTP Na-salt (Fermentas, Vilnius,
Lithuania), were tested separately to determine the opti-
mal concentration range for both. Experiments were rep-
licated at least three times.
NASBA product purification and labelling
Following amplification, NASBA products were purified
with NucleoSpin RNA Clean-Up kit (Macherey-Nagel,
Düren, Germany) and vacuum dried. Labeling of the RNA
product was carried out using protocol published by 't
Hoen and colleagues with some modifications [12]. The
RNA pellet was resuspended in 8,5 μl 0,1 M Na2CO3 and
incubated for one hour with 3 nmoles of amino reactive
Cy3-N-hydroxysuccinimide ester dye (Enzo, Farmingdale,
NY, USA) dissolved in 0,5 μl DMSO (Applichem, Darm-
stadt, Germany). Excess dye was quenched by addition of
3,5 μl 4 M hydroxylamine solution (Sigma-Aldrich, Stein-
heim, Germany). Labeled RNA was purified with Nucle-
oSpin kit and quantified using Bioanalyzer 2100 platform
with RNA 6000 Nano Chip (both Agilent, Santa Clara,
CA, USA) according to the manufacturers manual.
S. pneumoniae specific microarray
The custom made microarray contained 97 probes, cover-
ing whole S. pneumoniae tmRNA sequence (see Additional
file 1). Probes were designed with the SLICSel 1.0 software
http://bioinfo.ut.ee/slicsel. The average length of probes
was 16 nucleotides, their average Tm was 58°C and aver-
age ΔG-23 kcal/mol (calculated by DNA-RNA thermody-
namics). Probes were ordered from Metabion
(Mariensried, Germany) and spotted onto SAL-1 Ultra
microarray slides by Asper Biotech (Tartu, Estonia).
Microarray hybridization
One third of the labeled NASBA product was resuspended
in 80 μl of microarray hybridization buffer and hybrid-
ized for four hours on the S. pneumoniae specific microar-
ray in an automated HS-400 hybridization station (Tecan
Austria, Grödig, Austria) at 34°C. Complete hybridization
protocol is shown in Table 2.
Microarray scanning and data analysis
Slides were scanned using Affymetrix 428 scanner (Santa
Clara, CA, USA) λ = 532 nm. Raw signal intensity data was
analyzed with Genorama software (Asper Biotech). Fixed
concentration of short fluorescent oligonucleotide con-
trol sequences ('spikes'), complementary to the control
Table 1: Streptococcus pneumoniae NASBA primers used in current experiment
Primer Sequence 5'-> 3'
Forward +T7 AATTCTAATACGACTCACTATAGGGAGAAGGTTCGACAGGCATTATGAGGCATA
Reverse CGTCCAAACACCTGCCAACATABMC Biotechnology 2009, 9:45 http://www.biomedcentral.com/1472-6750/9/45
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oligonucleotides on microarray, were added to the final
80 μl hybridization solution for normalization purposes.
At first step all signals from all microarrays, obtained from
dilution series experiment, were rescaled by equating the
average of spike-specific signals. Secondly, to compare
data from 97 different probes on single microarray, all
individual signal intensities were divided with the corre-
sponding probe specific average signal intensity calcu-
lated over all microarrays in one replicate experiment.
Average over probe-wise normalized signal intensities
(relative microarray signal intensities) were then calcu-
lated for each dilution series point (for each single micro-
array). Finally, considering replicate experiments (at least
three), confidence intervals (± one SD) were calculated for
each average dilution series point (for every different
aaUTP concentration).
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